%0 Journal Article
%T Magnetic resonance imaging-guided radiofrequency ablation of breast cancer: a current state of the art review.
%A Zhang C
%A Shi J
%A Li B
%A Yu X
%A Feng X
%A Yang H
%J Diagn Interv Radiol
%V 30
%N 1
%D 01 2024 8
%M 36971252
暂无%R 10.4274/dir.2022.221429
%X With a gradual increase in breast cancer incidence and mortality rates and an urgent need to improve patient prognosis and cosmetology, magnetic resonance imaging (MRI)-guided radiofrequency ablation (RFA) therapy has attracted wide attention as a new treatment method for breast cancer. MRI-RFA results in a higher complete ablation rate and extremely low recurrence and complication rates. Thus, it may be used as an independent treatment for breast cancer or adjuvant to breast-conserving surgery to reduce the extent of breast resection. Furthermore, with MRI guidance, accurate control of RFA can be achieved, and breast cancer treatment can enter a new stage of minimally invasive, safe, and comprehensive therapy. With progress in MR thermometry technology, the applications of MRI are expected to broaden.